 | • レポートコード：MRC2-11QY03849 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は乗り物酔い治療のグローバル市場について調査・分析したレポートです。種類別（抗コリン作用薬、抗ヒスタミン薬、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別乗り物酔い治療の競争状況、市場シェア ・世界の乗り物酔い治療市場：種類別市場規模 2015年-2020年（抗コリン作用薬、抗ヒスタミン薬、その他） ・世界の乗り物酔い治療市場：種類別市場規模予測 2021年-2026年（抗コリン作用薬、抗ヒスタミン薬、その他） ・世界の乗り物酔い治療市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の乗り物酔い治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の乗り物酔い治療市場分析：米国、カナダ ・ヨーロッパの乗り物酔い治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの乗り物酔い治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の乗り物酔い治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの乗り物酔い治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline、Perrigo Company、Prestige Brands、WellSpring Pharmaceutical Corporation、Caleb Pharmaceuticals、Myungmoon Pharm、Baxter International、Reliefband Technologies ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
Motion sickness is a common condition experienced by around 50% to 60% of the general global population. It is more common in children and elderly. Various prescription and over the counter (OTC) drugs and products are available for treat motion sickness.
Market Analysis and Insights: Global Motion Sickness Treatment Market
The global Motion Sickness Treatment market size is projected to reach US$ 566.4 million by 2026, from US$ 552.1 million in 2020, at a CAGR of 2.4%% during 2021-2026.
Global Motion Sickness Treatment Scope and Market Size
Motion Sickness Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Motion Sickness Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
GlaxoSmithKline
Perrigo Company
Prestige Brands
WellSpring Pharmaceutical Corporation
Caleb Pharmaceuticals
Myungmoon Pharm
Baxter International
Reliefband Technologies
Market segment by Type, the product can be split into
Anticholinergic
Antihistamines
Others
Market segment by Application, split into
Hospitals
Clinics
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Motion Sickness Treatment Revenue
1.4 Market by Type
1.4.1 Global Motion Sickness Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anticholinergic
1.4.3 Antihistamines
1.4.4 Others
1.5 Market by Application
1.5.1 Global Motion Sickness Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Motion Sickness Treatment Market Perspective (2015-2026)
2.2 Global Motion Sickness Treatment Growth Trends by Regions
2.2.1 Motion Sickness Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Motion Sickness Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Motion Sickness Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Motion Sickness Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Motion Sickness Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Motion Sickness Treatment Players by Market Size
3.1.1 Global Top Motion Sickness Treatment Players by Revenue (2015-2020)
3.1.2 Global Motion Sickness Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Motion Sickness Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Motion Sickness Treatment Market Concentration Ratio
3.2.1 Global Motion Sickness Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Motion Sickness Treatment Revenue in 2019
3.3 Motion Sickness Treatment Key Players Head office and Area Served
3.4 Key Players Motion Sickness Treatment Product Solution and Service
3.5 Date of Enter into Motion Sickness Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Motion Sickness Treatment Historic Market Size by Type (2015-2020)
4.2 Global Motion Sickness Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Motion Sickness Treatment Market Size by Application (2015-2020)
5.2 Global Motion Sickness Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Motion Sickness Treatment Market Size (2015-2020)
6.2 Motion Sickness Treatment Key Players in North America (2019-2020)
6.3 North America Motion Sickness Treatment Market Size by Type (2015-2020)
6.4 North America Motion Sickness Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Motion Sickness Treatment Market Size (2015-2020)
7.2 Motion Sickness Treatment Key Players in Europe (2019-2020)
7.3 Europe Motion Sickness Treatment Market Size by Type (2015-2020)
7.4 Europe Motion Sickness Treatment Market Size by Application (2015-2020)
8 China
8.1 China Motion Sickness Treatment Market Size (2015-2020)
8.2 Motion Sickness Treatment Key Players in China (2019-2020)
8.3 China Motion Sickness Treatment Market Size by Type (2015-2020)
8.4 China Motion Sickness Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Motion Sickness Treatment Market Size (2015-2020)
9.2 Motion Sickness Treatment Key Players in Japan (2019-2020)
9.3 Japan Motion Sickness Treatment Market Size by Type (2015-2020)
9.4 Japan Motion Sickness Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Motion Sickness Treatment Market Size (2015-2020)
10.2 Motion Sickness Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Motion Sickness Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Motion Sickness Treatment Market Size by Application (2015-2020)
11 India
11.1 India Motion Sickness Treatment Market Size (2015-2020)
11.2 Motion Sickness Treatment Key Players in India (2019-2020)
11.3 India Motion Sickness Treatment Market Size by Type (2015-2020)
11.4 India Motion Sickness Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Motion Sickness Treatment Market Size (2015-2020)
12.2 Motion Sickness Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Motion Sickness Treatment Market Size by Type (2015-2020)
12.4 Central & South America Motion Sickness Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Motion Sickness Treatment Introduction
13.1.4 GlaxoSmithKline Revenue in Motion Sickness Treatment Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Perrigo Company
13.2.1 Perrigo Company Company Details
13.2.2 Perrigo Company Business Overview
13.2.3 Perrigo Company Motion Sickness Treatment Introduction
13.2.4 Perrigo Company Revenue in Motion Sickness Treatment Business (2015-2020)
13.2.5 Perrigo Company Recent Development
13.3 Prestige Brands
13.3.1 Prestige Brands Company Details
13.3.2 Prestige Brands Business Overview
13.3.3 Prestige Brands Motion Sickness Treatment Introduction
13.3.4 Prestige Brands Revenue in Motion Sickness Treatment Business (2015-2020)
13.3.5 Prestige Brands Recent Development
13.4 WellSpring Pharmaceutical Corporation
13.4.1 WellSpring Pharmaceutical Corporation Company Details
13.4.2 WellSpring Pharmaceutical Corporation Business Overview
13.4.3 WellSpring Pharmaceutical Corporation Motion Sickness Treatment Introduction
13.4.4 WellSpring Pharmaceutical Corporation Revenue in Motion Sickness Treatment Business (2015-2020)
13.4.5 WellSpring Pharmaceutical Corporation Recent Development
13.5 Caleb Pharmaceuticals
13.5.1 Caleb Pharmaceuticals Company Details
13.5.2 Caleb Pharmaceuticals Business Overview
13.5.3 Caleb Pharmaceuticals Motion Sickness Treatment Introduction
13.5.4 Caleb Pharmaceuticals Revenue in Motion Sickness Treatment Business (2015-2020)
13.5.5 Caleb Pharmaceuticals Recent Development
13.6 Myungmoon Pharm
13.6.1 Myungmoon Pharm Company Details
13.6.2 Myungmoon Pharm Business Overview
13.6.3 Myungmoon Pharm Motion Sickness Treatment Introduction
13.6.4 Myungmoon Pharm Revenue in Motion Sickness Treatment Business (2015-2020)
13.6.5 Myungmoon Pharm Recent Development
13.7 Baxter International
13.7.1 Baxter International Company Details
13.7.2 Baxter International Business Overview
13.7.3 Baxter International Motion Sickness Treatment Introduction
13.7.4 Baxter International Revenue in Motion Sickness Treatment Business (2015-2020)
13.7.5 Baxter International Recent Development
13.8 Reliefband Technologies
13.8.1 Reliefband Technologies Company Details
13.8.2 Reliefband Technologies Business Overview
13.8.3 Reliefband Technologies Motion Sickness Treatment Introduction
13.8.4 Reliefband Technologies Revenue in Motion Sickness Treatment Business (2015-2020)
13.8.5 Reliefband Technologies Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Motion Sickness Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Motion Sickness Treatment Revenue
Table 3. Ranking of Global Top Motion Sickness Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Motion Sickness Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Anticholinergic
Table 6. Key Players of Antihistamines
Table 7. Key Players of Others
Table 8. Global Motion Sickness Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Motion Sickness Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Motion Sickness Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Motion Sickness Treatment Market Share by Regions (2015-2020)
Table 12. Global Motion Sickness Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Motion Sickness Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Motion Sickness Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Motion Sickness Treatment Players
Table 19. Global Motion Sickness Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Motion Sickness Treatment Market Share by Players (2015-2020)
Table 21. Global Top Motion Sickness Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Motion Sickness Treatment as of 2019)
Table 22. Global Motion Sickness Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Motion Sickness Treatment Product Solution and Service
Table 25. Date of Enter into Motion Sickness Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Motion Sickness Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Motion Sickness Treatment Market Size Share by Type (2015-2020)
Table 29. Global Motion Sickness Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Motion Sickness Treatment Market Size Share by Application (2015-2020)
Table 31. Global Motion Sickness Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Motion Sickness Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Motion Sickness Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Motion Sickness Treatment Market Share (2019-2020)
Table 35. North America Motion Sickness Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Motion Sickness Treatment Market Share by Type (2015-2020)
Table 37. North America Motion Sickness Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Motion Sickness Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Motion Sickness Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Motion Sickness Treatment Market Share (2019-2020)
Table 41. Europe Motion Sickness Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Motion Sickness Treatment Market Share by Type (2015-2020)
Table 43. Europe Motion Sickness Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Motion Sickness Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Motion Sickness Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Motion Sickness Treatment Market Share (2019-2020)
Table 47. China Motion Sickness Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Motion Sickness Treatment Market Share by Type (2015-2020)
Table 49. China Motion Sickness Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Motion Sickness Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Motion Sickness Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Motion Sickness Treatment Market Share (2019-2020)
Table 53. Japan Motion Sickness Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Motion Sickness Treatment Market Share by Type (2015-2020)
Table 55. Japan Motion Sickness Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Motion Sickness Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Motion Sickness Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Motion Sickness Treatment Market Share (2019-2020)
Table 59. Southeast Asia Motion Sickness Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Motion Sickness Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Motion Sickness Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Motion Sickness Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Motion Sickness Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Motion Sickness Treatment Market Share (2019-2020)
Table 65. India Motion Sickness Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Motion Sickness Treatment Market Share by Type (2015-2020)
Table 67. India Motion Sickness Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Motion Sickness Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Motion Sickness Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Motion Sickness Treatment Market Share (2019-2020)
Table 71. Central & South America Motion Sickness Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Motion Sickness Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Motion Sickness Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Motion Sickness Treatment Market Share by Application (2015-2020)
Table 75. GlaxoSmithKline Company Details
Table 76. GlaxoSmithKline Business Overview
Table 77. GlaxoSmithKline Product
Table 78. GlaxoSmithKline Revenue in Motion Sickness Treatment Business (2015-2020) (Million US$)
Table 79. GlaxoSmithKline Recent Development
Table 80. Perrigo Company Company Details
Table 81. Perrigo Company Business Overview
Table 82. Perrigo Company Product
Table 83. Perrigo Company Revenue in Motion Sickness Treatment Business (2015-2020) (Million US$)
Table 84. Perrigo Company Recent Development
Table 85. Prestige Brands Company Details
Table 86. Prestige Brands Business Overview
Table 87. Prestige Brands Product
Table 88. Prestige Brands Revenue in Motion Sickness Treatment Business (2015-2020) (Million US$)
Table 89. Prestige Brands Recent Development
Table 90. WellSpring Pharmaceutical Corporation Company Details
Table 91. WellSpring Pharmaceutical Corporation Business Overview
Table 92. WellSpring Pharmaceutical Corporation Product
Table 93. WellSpring Pharmaceutical Corporation Revenue in Motion Sickness Treatment Business (2015-2020) (Million US$)
Table 94. WellSpring Pharmaceutical Corporation Recent Development
Table 95. Caleb Pharmaceuticals Company Details
Table 96. Caleb Pharmaceuticals Business Overview
Table 97. Caleb Pharmaceuticals Product
Table 98. Caleb Pharmaceuticals Revenue in Motion Sickness Treatment Business (2015-2020) (Million US$)
Table 99. Caleb Pharmaceuticals Recent Development
Table 100. Myungmoon Pharm Company Details
Table 101. Myungmoon Pharm Business Overview
Table 102. Myungmoon Pharm Product
Table 103. Myungmoon Pharm Revenue in Motion Sickness Treatment Business (2015-2020) (Million US$)
Table 104. Myungmoon Pharm Recent Development
Table 105. Baxter International Company Details
Table 106. Baxter International Business Overview
Table 107. Baxter International Product
Table 108. Baxter International Revenue in Motion Sickness Treatment Business (2015-2020) (Million US$)
Table 109. Baxter International Recent Development
Table 110. Reliefband Technologies Business Overview
Table 111. Reliefband Technologies Product
Table 112. Reliefband Technologies Company Details
Table 113. Reliefband Technologies Revenue in Motion Sickness Treatment Business (2015-2020) (Million US$)
Table 114. Reliefband Technologies Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Motion Sickness Treatment Market Share by Type: 2020 VS 2026
Figure 2. Anticholinergic Features
Figure 3. Antihistamines Features
Figure 4. Others Features
Figure 5. Global Motion Sickness Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Motion Sickness Treatment Report Years Considered
Figure 10. Global Motion Sickness Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Motion Sickness Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Motion Sickness Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Motion Sickness Treatment Market Share by Players in 2019
Figure 15. Global Top Motion Sickness Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Motion Sickness Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Motion Sickness Treatment Revenue in 2019
Figure 17. North America Motion Sickness Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Motion Sickness Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Motion Sickness Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Motion Sickness Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Motion Sickness Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Motion Sickness Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Motion Sickness Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
睡眠病検査の世界市場（～2026年） Sleeping sickness is a disease caused by infection with the flagellate protozoan Trypanosoma brucei gambiense or the closely related subspecies T.brucei rhodesiense. Growing technological advancement in molecular and clinical microbiology techniques are expected to drive the sleeping sickness testin…- モーション保存デバイスの世界市場（～2026年） Market Analysis and Insights: Global Motion Preservation Devices Market The global Motion Preservation Devices market size is projected to reach US$ 576.6 million by 2026, from US$ 544.6 million in 2020, at a CAGR of 5.4%% during 2021-2026. Global Motion Preservation Devices Scope and Market Size Mo…
- スローモーションカメラの世界市場（～2026年） A Slow Motion Camera is a device capable of capturing moving images with exposures of less than 1/1,000 second or frame rates in excess of 250 frames per second.[1] It is used for recording fast-moving objects as photographic images onto a storage medium. Market Analysis and Insights: Global Slow Mo…
- 交流電場腫瘍治療の世界市場（～2026年） Alternating electric field tumor therapy is an anticancer treatment which disrupts the tumor cells mitosis. Alternating electric field therapy is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer. The alternating e…
- アレルギー性鼻炎治療の世界市場（～2026年） The common name for allergic rhinitis is hay fever. It is diagnosed when symptoms appear which includes itchy nose, mouth, eyes, throat, skin, as well as other parts of the body; along with this other symptoms includes running nose, sneezing, watery eyes, problem during smelling, cough and sore th…